Evidence map›Paper›PMID 38493188›Full record

ArticleNPJ Parkinson's disease2024

Advanced brain aging in Parkinson's disease with cognitive impairment.

Chang-Le Chen, Shao-Ying Cheng, Leila Montaser-Kouhsari, Wen-Chao Wu, Yung-Chin Hsu, Chun-Hwei Tai, Wen-Yih Isaac Tseng, Ming-Che Kuo, Ruey-Meei Wu

Open access · goldAbstract read
In one paragraph

Article in NPJ Parkinson's disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. [Research progress on intelligent brain age prediction methods in diagnosis of Parkinson's disease].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Advanced brain aging, selective vulnerability in gray matter, and cognition in Parkinson's disease.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Chang-Le ChenInstitute of Medical Device and Imaging, National Taiwan University College of Medicine, Taipei, Taiwan.
Shao-Ying ChengDepartment of Neurology, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan.
Leila Montaser-KouhsariDepartment of Neurology, Harvard University, Boston, MA, USA.
Wen-Chao WuInstitute of Medical Device and Imaging, National Taiwan University College of Medicine, Taipei, Taiwan.
Yung-Chin HsuAcroviz Inc, Taipei, Taiwan.ORCID http://orcid.org/0000-0002-4931-1892
Chun-Hwei TaiDepartment of Neurology, National Taiwan University Hospital, Taipei, Taiwan.
Wen-Yih Isaac TsengInstitute of Medical Device and Imaging, National Taiwan University College of Medicine, Taipei, Taiwan. wytseng@ntu.edu.tw.
Ming-Che KuoDepartment of Neurology, National Taiwan University Hospital, Taipei, Taiwan. A00568@ntucc.gov.tw.ORCID http://orcid.org/0000-0003-3688-0225
Ruey-Meei WuDepartment of Neurology, National Taiwan University Hospital, Taipei, Taiwan.
National Taiwan University · TWNational Taiwan University Hospital · TWHarvard University · US

Funding

National Taiwan University (NTU) UN109-064
6 · The paper itself

Abstract

Patients with Parkinson's disease and cognitive impairment (PD-CI) deteriorate faster than those without cognitive impairment (PD-NCI), suggesting an underlying difference in the neurodegeneration process. We aimed to verify brain age differences in PD-CI and PD-NCI and their clinical significance. A total of 94 participants (PD-CI, n = 27; PD-NCI, n = 34; controls, n = 33) were recruited. Predicted age difference (PAD) based on gray matter (GM) and white matter (WM) features were estimated to represent the degree of brain aging. Patients with PD-CI showed greater GM-PAD (7.08 ± 6.64 years) and WM-PAD (8.82 ± 7.69 years) than those with PD-NCI (GM: 1.97 ± 7.13, P

Identifiers

PMID38493188
PMCPMC10944471
OpenAlexW4392880828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.